Gilead Sciences, Inc. (GILD) operating KPIs
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)
Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%
Latest, Q2 2026
11,744
Period ended Jun 30, 2026
Change on a year earlier
-40.1%
19,590 in Q2 2025
History
71 quarters
Since Q4 2006
Sources
65
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total stockholders' equity ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 11,744 | -40.1% | Form 10-Q (filed 2026-08-06) ↗ |
| Q1 2026 | Mar 31, 2026 | 23,431 | +22.8% | Form 10-Q (filed 2026-05-07) ↗ |
| Q4 2025 | Dec 31, 2025 | 22,618 | +17.5% | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2025 | Sep 30, 2025 | 21,456 | +16.7% | Form 10-Q (filed 2025-11-07) ↗ |
| Q2 2025 | Jun 30, 2025 | 19,590 | +7.7% | Form 10-Q (filed 2025-08-07) ↗ |
| Q1 2025 | Mar 31, 2025 | 19,078 | +9.3% | Form 10-Q (filed 2025-05-07) ↗ |
| Q4 2024 | Dec 31, 2024 | 19,246 | -15.4% | Form 10-K (filed 2025-02-28) ↗ |
| Q3 2024 | Sep 30, 2024 | 18,390 | -17.3% | Form 10-Q (filed 2024-11-12) ↗ |
| Q2 2024 | Jun 30, 2024 | 18,197 | -13.7% | Form 10-Q (filed 2024-08-08) ↗ |
| Q1 2024 | Mar 31, 2024 | 17,455 | -16.6% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2023 | Dec 31, 2023 | 22,749 | +7.3% | Form 10-K (filed 2024-02-23) ↗ |
| Q3 2023 | Sep 30, 2023 | 22,242 | +5.6% | Form 10-Q (filed 2023-11-07) ↗ |
| Q2 2023 | Jun 30, 2023 | 21,094 | +4.3% | Form 10-Q (filed 2023-08-04) ↗ |
| Q1 2023 | Mar 31, 2023 | 20,939 | +5.1% | Form 10-Q (filed 2023-05-03) ↗ |
| Q4 2022 | Dec 31, 2022 | 21,209 | +0.7% | Form 10-K (filed 2023-02-22) ↗ |
| Q3 2022 | Sep 30, 2022 | 21,057 | -1.9% | Form 10-Q (filed 2022-11-02) ↗ |
| Q2 2022 | Jun 30, 2022 | 20,215 | +2.6% | Form 10-Q (filed 2022-08-08) ↗ |
| Q1 2022 | Mar 31, 2022 | 19,915 | +5.0% | Form 10-Q (filed 2022-05-04) ↗ |
| Q4 2021 | Dec 31, 2021 | 21,064 | +15.6% | Form 10-K (filed 2022-02-23) ↗ |
| Q3 2021 | Sep 30, 2021 | 21,471 | +22.9% | Form 10-Q (filed 2021-11-03) ↗ |
| Q2 2021 | Jun 30, 2021 | 19,710 | +8.6% | Form 10-Q (filed 2021-08-05) ↗ |
| Q1 2021 | Mar 31, 2021 | 18,964 | -14.5% | Form 10-Q (filed 2021-05-06) ↗ |
| Q4 2020 | Dec 31, 2020 | 18,221 | -19.6% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | 17,471 | -15.7% | Form 10-Q (filed 2020-11-04) ↗ |
| Q2 2020 | Jun 30, 2020 | 18,142 | -20.3% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2020 | Mar 31, 2020 | 22,179 | +0.4% | Form 10-Q (filed 2020-05-06) ↗ |
| Q4 2019 | Dec 31, 2019 | 22,650 | +5.2% | Form 10-K (filed 2020-02-25) ↗ |
| Q3 2019 | Sep 30, 2019 | 20,736 | -9.9% | Form 10-Q (filed 2019-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | 22,751 | +4.7% | Form 10-Q (filed 2019-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | 22,091 | +7.0% | Form 10-Q (filed 2019-05-08) ↗ |
| Q4 2018 | Dec 31, 2018 | 21,534 | +5.0% | Form 10-K (filed 2019-02-26) ↗ |
| Q3 2018 | Sep 30, 2018 | 23,007 | -8.9% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 21,734 | -5.9% | Form 10-Q (filed 2018-08-06) ↗ |
| Q1 2018 | Mar 31, 2018 | 20,651 | -1.3% | Form 10-Q (filed 2018-05-09) ↗ |
| Q4 2017 | Dec 31, 2017 | 20,501 | +5.9% | Form 10-K (filed 2018-02-27) ↗ |
| Q3 2017 | Sep 30, 2017 | 25,254 | +45.5% | Form 10-Q (filed 2017-11-07) ↗ |
| Q2 2017 | Jun 30, 2017 | 23,091 | +43.3% | Form 10-Q (filed 2017-08-07) ↗ |
| Q1 2017 | Mar 31, 2017 | 20,917 | +49.2% | Form 10-Q (filed 2017-05-10) ↗ |
| Q4 2016 | Dec 31, 2016 | 19,363 | +1.3% | Form 10-K (filed 2017-02-27) ↗ |
| Q3 2016 | Sep 30, 2016 | 17,360 | -3.3% | Form 10-Q (filed 2016-11-07) ↗ |
| Q2 2016 | Jun 30, 2016 | 16,115 | -3.1% | Form 10-Q (filed 2016-08-05) ↗ |
| Q1 2016 | Mar 31, 2016 | 14,019 | -20.3% | Form 10-Q (filed 2016-05-06) ↗ |
| Q4 2015 | Dec 31, 2015 | 19,113 | +20.8% | Form 10-K (filed 2016-02-24) ↗ |
| Q3 2015 | Sep 30, 2015 | 17,944 | +29.4% | Form 10-Q (filed 2015-11-04) ↗ |
| Q2 2015 | Jun 30, 2015 | 16,634 | +1.2% | Form 10-Q (filed 2015-08-05) ↗ |
| Q1 2015 | Mar 31, 2015 | 17,588 | +28.4% | Form 10-Q (filed 2015-05-08) ↗ |
| Q4 2014 | Dec 31, 2014 | 15,819 | +34.7% | Form 10-K (filed 2015-02-25) ↗ |
| Q3 2014 | Sep 30, 2014 | 13,864 | +23.9% | SEC Filing ↗ |
| Q2 2014 | Jun 30, 2014 | 16,429 | +44.8% | SEC Filing ↗ |
| Q1 2014 | Mar 31, 2014 | 13,702 | +31.8% | SEC Filing ↗ |
| Q4 2013 | Dec 31, 2013 | 11,745 | +23.1% | Form 10-K (filed 2015-02-25) ↗ |
| Q3 2013 | Sep 30, 2013 | 11,193 | +27.9% | Form 10-Q (filed 2013-10-31) ↗ |
| Q2 2013 | Jun 30, 2013 | 11,343 | +40.3% | Form 10-Q (filed 2013-08-01) ↗ |
| Q1 2013 | Mar 31, 2013 | 10,393 | +41.1% | Form 10-Q (filed 2013-05-08) ↗ |
| Q4 2012 | Dec 31, 2012 | 9,544 | +39.0% | Form 10-K (filed 2015-02-25) ↗ |
| Q3 2012 | Sep 30, 2012 | 8,750 | +40.4% | Form 10-Q (filed 2012-11-06) ↗ |
| Q2 2012 | Jun 30, 2012 | 8,083 | +30.1% | Form 10-Q (filed 2012-08-01) ↗ |
| Q1 2012 | Mar 31, 2012 | 7,364 | +19.2% | Form 10-Q (filed 2012-05-04) ↗ |
| Q4 2011 | Dec 31, 2011 | 6,867 | +12.2% | Form 10-K (filed 2015-02-25) ↗ |
| Q3 2011 | Sep 30, 2011 | 6,233 | +6.0% | Form 10-Q (filed 2011-11-04) ↗ |
| Q2 2011 | Jun 30, 2011 | 6,211 | – | Form 10-Q (filed 2011-08-05) ↗ |
| Q1 2011 | Mar 31, 2011 | 6,175 | -17.7% | Form 10-Q (filed 2011-05-09) ↗ |
| Q4 2010 | Dec 31, 2010 | 6,122 | -5.9% | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2010 | Sep 30, 2010 | 5,879 | +2.2% | Form 10-Q (filed 2010-11-08) ↗ |
| Q1 2010 | Mar 31, 2010 | 7,503 | – | Form 10-Q (filed 2010-05-10) ↗ |
| Q4 2009 | Dec 31, 2009 | 6,505 | +45.7% | Form 10-K (filed 2010-03-01) ↗ |
| Q3 2009 | Sep 30, 2009 | 5,752 | – | Form 10-Q (filed 2009-11-05) ↗ |
| Q2 2009 | Jun 30, 2009 | 5,314 | – | Form 10-Q (filed 2009-08-05) ↗ |
| Q4 2008 | Dec 31, 2008 | 4,466 | +19.0% | Form 10-Q (filed 2009-08-05) ↗ |
| Q4 2007 | Dec 31, 2007 | 3,753 | +82.9% | Form 10-K (filed 2010-03-01) ↗ |
| Q4 2006 | Dec 31, 2006 | 2,052 | – | Form 10-K (filed 2010-03-01) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Total stockholders' equity ($M) ($M), quarterly Q4 2006–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/fs_eq
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.